References
- Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. Arch Otolaryngol 1980; 106: 772–6.
- Mattox DE, Lyles CA. Idiopathic sudden sensorineural hearing loss. Am J Otol 1989; 10: 242–7.
- Hughes GB, Freedman MA, Haberkamp TJ, Guay ME. Sudden sensorineural hearing loss. Otolaryngol Clin North Am 1996; 29: 393–405.
- McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979; 88: 585–9.
- Ryan AF, Keithley EM, Harris JP. Autoimmune inner ear disorders. Curr Opin Neurol 2001; 14: 35–40.
- Stone JH, Francis HW. Immune-mediated inner ear disease. Curr Opin Rheumatol 2000; 12: 32–40.
- Yoo TJ, Tomoda K, Stuart JM, Cremer MA, Townes AS, Kang AH. Type II collagen induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats. Ann Rhinol Otol Laryngol 1983; 92: 267–71.
- Joliat T, Seyer J, Bernstein J, et al. Antibodies against a 30 kDa cochlear protein and type II and type IX collagens in the serum of patients with inner ear disease. Ann Otol Rhinol Laryngol 1992; 101: 1000–6.
- Boulassel MR, Deggouj N, Tomasi JP, Gersdorf M. Inner ear autoantibodies and their targets in patients with autoimmune inner ear diseases. Acta Otolaryngol 2001; 121: 28–34.
- Veldman JE, Hanada T, Meeuwsen F. Diagnostic and therapeutic dilemmas in rapidly progressive sensorineural hearing loss and sudden hearing loss. A reappraisal of immune reactivity in inner ear disorders. Acta Otolar-yngol (Stockh) 1993; 113: 303–6.
- ToubiE, Ben-David J, Kessel A, Podoshin L, Golan TD. Autoimmune aberration in sudden sensorineural hearing loss: association with anti-cardiolipin antibodies. Lupus 1997; 6: 540–2.
- Heller U, Becker EW, Zenner HP, Berg PA. Incidence and clinical relevance of antibodies to phospholipids, serotonin and ganglioside in patients with sudden deaf-ness and progressive inner ear hearing loss. HNO 1998; 46: 583–6.
- Mayot D, Bene MC, Dron K, Perrin C, Faure GC. Immunologic alterations in patients with sensorineural hearing disorders. Clin Immunol Immunopathol 1993; 68: 41–5.
- Garcia Berrocal JR, Ramirez Camacho R. Immune response and immunopathology of the inner ear: an update. J Laryngol Otol 2000; 114: 101–7.
- Nordang L, Laurent C, Mollnes TE. Complement acti-vation in sudden deafness. Arch Otolaryngol Head Neck Surg 1998; 124: 633–6.
- Belizna C, Cohen Tervaert JW. Specificity, pathogenicity and clinical value of anti-endothelial cell antibodies. Semin Arthritis Rheum 2000; 27: 98–109.
- Tan EM, Pearson CM. Rheumatic disease sera reactive with capillaries in the mouse kidney. Arthritis Rheum 1972; 15: 23–8.
- Hill MB, Phipps JL, Milford-Ward A, Greaves M, Hughes P. Further characterization of anti-endothelial cell antibodies in systemic lupus erythematosus by con-trolled immunoblotting. Br J Rheumatol 1996; 35: 123 1–8.
- Meroni PL, D 'Cruz D, Khamashta M, Youinou O, Hughes GRV. Anti-endothelial cell antibodies: only for scientists or for clinicians too? Clin Exp Immunol 1996; 104: 199–202.
- Vasama JP, Linthicum FH Jr. Idiopathic sudden sen-sorineural hearing loss: a temporal bone histopathologic study. Ann Otol Rhinol Laryngol 2000; 109: 527–32.
- Lin DW, Trune DR. Breakdown of stria vascularis blood-labyrinth barrier in C3H/Ipr autoimmune disease mice. Otolaryngol Head Neck Surg 1997; 117: 530–4.
- Yoon TH, Paparella MM, Schachern PA. Systemic vasculitis: a temporal bone histopathologic study. Laryngoscope 1989; 99: 600–9.
- Bykovskaia GN, Slepova OS, Krichevskaia GI, Katargina LA, Kushnir VN. Study of antibodies to DNA in patients with bilateral and unilateral endoge-nous uveitis. Vestn Oftalmol 1997; 113: 30–2.
- Lyons JL, Rosenbaum JT. Uveitis associated with infl-ammatory bowel disease compared with uveitis associ-ated with spondyloarthropathy. Arch Ophthalmol 1997; 115: 61–4.